ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
rdf:type |
node1 |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
rdf:type |
prov:Person |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
http://www.w3.org/ns/org#memberOf |
ripekg:organization/RIPEOAE194BE6899690F0Department of Community Nutrition |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
foaf:familyName |
Askari |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
foaf:givenName |
Gholamreza |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
foaf:name |
Gholamreza Askari |
ripekg:retraction-notice/28473Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients |
ripe:concerns |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
ripekg:work/10.1136%2Fbmjopen-2024-093167Effect of saffron supplementation on Parkinson’s disease: a study protocol for a triple-blind randomised controlled clinical trial |
dcterms:creator |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |
ripekg:work/10.1136%2Fbmjopen-2024-093167Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAU9A36A8582D4E8F0CGholamreza Askari |